Favipiravir Industry Research Report 2023
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
Highlights
The global Favipiravir market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Favipiravir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Favipiravir.
The Favipiravir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Favipiravir market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Favipiravir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Favipiravir type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Favipiravir are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Favipiravir segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Favipiravir market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Favipiravir market.
Favipiravir segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Favipiravir market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Favipiravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Favipiravir and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Favipiravir industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Favipiravir.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Favipiravir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Favipiravir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Favipiravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Favipiravir market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market. Favipiravir is widely used for Influenza Viruses, COVID-19, etc. The most proportion of Favipiravir is used for COVID-19 and the proportion is 97%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Favipiravir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Favipiravir.
The Favipiravir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Favipiravir market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Favipiravir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- ChemRar Group
- Glenmark
- Fujifilm
- Dr. Reddy
- R-Pharma
- Cipla
- Lupin
- Sun Pharma
- Hisun Pharm
Global markets are presented by Favipiravir type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Favipiravir are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Favipiravir segment by Type
- Brand Drug
- Generic Drug
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Favipiravir market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Favipiravir market.
Favipiravir segment by Application
- Influenza Viruses
- COVID-19
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Favipiravir market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Favipiravir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Favipiravir and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Favipiravir industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Favipiravir.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Favipiravir manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Favipiravir by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Favipiravir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Favipiravir Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Favipiravir Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Favipiravir Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Favipiravir Revenue of Manufacturers (2018-2023)
Table 9. Global Favipiravir Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Favipiravir Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Favipiravir Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Favipiravir, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Favipiravir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. ChemRar Group Company Information
Table 17. ChemRar Group Business Overview
Table 18. ChemRar Group Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. ChemRar Group Favipiravir Product Portfolio
Table 20. ChemRar Group Recent Developments
Table 21. Glenmark Company Information
Table 22. Glenmark Business Overview
Table 23. Glenmark Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Glenmark Favipiravir Product Portfolio
Table 25. Glenmark Recent Developments
Table 26. Fujifilm Company Information
Table 27. Fujifilm Business Overview
Table 28. Fujifilm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Fujifilm Favipiravir Product Portfolio
Table 30. Fujifilm Recent Developments
Table 31. Dr. Reddy Company Information
Table 32. Dr. Reddy Business Overview
Table 33. Dr. Reddy Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Dr. Reddy Favipiravir Product Portfolio
Table 35. Dr. Reddy Recent Developments
Table 36. R-Pharma Company Information
Table 37. R-Pharma Business Overview
Table 38. R-Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. R-Pharma Favipiravir Product Portfolio
Table 40. R-Pharma Recent Developments
Table 41. Cipla Company Information
Table 42. Cipla Business Overview
Table 43. Cipla Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Cipla Favipiravir Product Portfolio
Table 45. Cipla Recent Developments
Table 46. Lupin Company Information
Table 47. Lupin Business Overview
Table 48. Lupin Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Lupin Favipiravir Product Portfolio
Table 50. Lupin Recent Developments
Table 51. Sun Pharma Company Information
Table 52. Sun Pharma Business Overview
Table 53. Sun Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Sun Pharma Favipiravir Product Portfolio
Table 55. Sun Pharma Recent Developments
Table 56. Hisun Pharm Company Information
Table 57. Hisun Pharm Business Overview
Table 58. Hisun Pharm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Hisun Pharm Favipiravir Product Portfolio
Table 60. Hisun Pharm Recent Developments
Table 61. Global Favipiravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Favipiravir Sales by Region (2018-2023) & (K Units)
Table 63. Global Favipiravir Sales Market Share by Region (2018-2023)
Table 64. Global Favipiravir Sales by Region (2024-2029) & (K Units)
Table 65. Global Favipiravir Sales Market Share by Region (2024-2029)
Table 66. Global Favipiravir Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Favipiravir Revenue Market Share by Region (2018-2023)
Table 68. Global Favipiravir Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Favipiravir Revenue Market Share by Region (2024-2029)
Table 70. North America Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Favipiravir Sales by Country (2018-2023) & (K Units)
Table 72. North America Favipiravir Sales by Country (2024-2029) & (K Units)
Table 73. North America Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Favipiravir Sales by Country (2018-2023) & (K Units)
Table 77. Europe Favipiravir Sales by Country (2024-2029) & (K Units)
Table 78. Europe Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Favipiravir Sales by Country (2018-2023) & (K Units)
Table 82. Asia Pacific Favipiravir Sales by Country (2024-2029) & (K Units)
Table 83. Asia Pacific Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Favipiravir Sales by Country (2018-2023) & (K Units)
Table 87. Latin America Favipiravir Sales by Country (2024-2029) & (K Units)
Table 88. Latin America Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Favipiravir Sales by Country (2018-2023) & (K Units)
Table 92. Middle East and Africa Favipiravir Sales by Country (2024-2029) & (K Units)
Table 93. Middle East and Africa Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Favipiravir Sales by Type (2018-2023) & (K Units)
Table 96. Global Favipiravir Sales by Type (2024-2029) & (K Units)
Table 97. Global Favipiravir Sales Market Share by Type (2018-2023)
Table 98. Global Favipiravir Sales Market Share by Type (2024-2029)
Table 99. Global Favipiravir Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Favipiravir Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Favipiravir Revenue Market Share by Type (2018-2023)
Table 102. Global Favipiravir Revenue Market Share by Type (2024-2029)
Table 103. Global Favipiravir Price by Type (2018-2023) & (US$/Unit)
Table 104. Global Favipiravir Price by Type (2024-2029) & (US$/Unit)
Table 105. Global Favipiravir Sales by Application (2018-2023) & (K Units)
Table 106. Global Favipiravir Sales by Application (2024-2029) & (K Units)
Table 107. Global Favipiravir Sales Market Share by Application (2018-2023)
Table 108. Global Favipiravir Sales Market Share by Application (2024-2029)
Table 109. Global Favipiravir Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Favipiravir Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Favipiravir Revenue Market Share by Application (2018-2023)
Table 112. Global Favipiravir Revenue Market Share by Application (2024-2029)
Table 113. Global Favipiravir Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Favipiravir Price by Application (2024-2029) & (US$/Unit)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Favipiravir Distributors List
Table 118. Favipiravir Customers List
Table 119. Favipiravir Industry Trends
Table 120. Favipiravir Industry Drivers
Table 121. Favipiravir Industry Restraints
Table 122. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Favipiravir Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Favipiravir Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Favipiravir Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Favipiravir Revenue of Manufacturers (2018-2023)
Table 9. Global Favipiravir Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Favipiravir Average Price (US$/Unit) of Manufacturers (2018-2023)
Table 11. Global Favipiravir Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Favipiravir, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Favipiravir by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. ChemRar Group Company Information
Table 17. ChemRar Group Business Overview
Table 18. ChemRar Group Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 19. ChemRar Group Favipiravir Product Portfolio
Table 20. ChemRar Group Recent Developments
Table 21. Glenmark Company Information
Table 22. Glenmark Business Overview
Table 23. Glenmark Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 24. Glenmark Favipiravir Product Portfolio
Table 25. Glenmark Recent Developments
Table 26. Fujifilm Company Information
Table 27. Fujifilm Business Overview
Table 28. Fujifilm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 29. Fujifilm Favipiravir Product Portfolio
Table 30. Fujifilm Recent Developments
Table 31. Dr. Reddy Company Information
Table 32. Dr. Reddy Business Overview
Table 33. Dr. Reddy Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 34. Dr. Reddy Favipiravir Product Portfolio
Table 35. Dr. Reddy Recent Developments
Table 36. R-Pharma Company Information
Table 37. R-Pharma Business Overview
Table 38. R-Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 39. R-Pharma Favipiravir Product Portfolio
Table 40. R-Pharma Recent Developments
Table 41. Cipla Company Information
Table 42. Cipla Business Overview
Table 43. Cipla Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 44. Cipla Favipiravir Product Portfolio
Table 45. Cipla Recent Developments
Table 46. Lupin Company Information
Table 47. Lupin Business Overview
Table 48. Lupin Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 49. Lupin Favipiravir Product Portfolio
Table 50. Lupin Recent Developments
Table 51. Sun Pharma Company Information
Table 52. Sun Pharma Business Overview
Table 53. Sun Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 54. Sun Pharma Favipiravir Product Portfolio
Table 55. Sun Pharma Recent Developments
Table 56. Hisun Pharm Company Information
Table 57. Hisun Pharm Business Overview
Table 58. Hisun Pharm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 59. Hisun Pharm Favipiravir Product Portfolio
Table 60. Hisun Pharm Recent Developments
Table 61. Global Favipiravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 62. Global Favipiravir Sales by Region (2018-2023) & (K Units)
Table 63. Global Favipiravir Sales Market Share by Region (2018-2023)
Table 64. Global Favipiravir Sales by Region (2024-2029) & (K Units)
Table 65. Global Favipiravir Sales Market Share by Region (2024-2029)
Table 66. Global Favipiravir Revenue by Region (2018-2023) & (US$ Million)
Table 67. Global Favipiravir Revenue Market Share by Region (2018-2023)
Table 68. Global Favipiravir Revenue by Region (2024-2029) & (US$ Million)
Table 69. Global Favipiravir Revenue Market Share by Region (2024-2029)
Table 70. North America Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. North America Favipiravir Sales by Country (2018-2023) & (K Units)
Table 72. North America Favipiravir Sales by Country (2024-2029) & (K Units)
Table 73. North America Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 74. North America Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 75. Europe Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Favipiravir Sales by Country (2018-2023) & (K Units)
Table 77. Europe Favipiravir Sales by Country (2024-2029) & (K Units)
Table 78. Europe Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 79. Europe Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 80. Asia Pacific Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 81. Asia Pacific Favipiravir Sales by Country (2018-2023) & (K Units)
Table 82. Asia Pacific Favipiravir Sales by Country (2024-2029) & (K Units)
Table 83. Asia Pacific Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 84. Asia Pacific Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 85. Latin America Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 86. Latin America Favipiravir Sales by Country (2018-2023) & (K Units)
Table 87. Latin America Favipiravir Sales by Country (2024-2029) & (K Units)
Table 88. Latin America Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 89. Latin America Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 90. Middle East and Africa Favipiravir Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Middle East and Africa Favipiravir Sales by Country (2018-2023) & (K Units)
Table 92. Middle East and Africa Favipiravir Sales by Country (2024-2029) & (K Units)
Table 93. Middle East and Africa Favipiravir Revenue by Country (2018-2023) & (US$ Million)
Table 94. Middle East and Africa Favipiravir Revenue by Country (2024-2029) & (US$ Million)
Table 95. Global Favipiravir Sales by Type (2018-2023) & (K Units)
Table 96. Global Favipiravir Sales by Type (2024-2029) & (K Units)
Table 97. Global Favipiravir Sales Market Share by Type (2018-2023)
Table 98. Global Favipiravir Sales Market Share by Type (2024-2029)
Table 99. Global Favipiravir Revenue by Type (2018-2023) & (US$ Million)
Table 100. Global Favipiravir Revenue by Type (2024-2029) & (US$ Million)
Table 101. Global Favipiravir Revenue Market Share by Type (2018-2023)
Table 102. Global Favipiravir Revenue Market Share by Type (2024-2029)
Table 103. Global Favipiravir Price by Type (2018-2023) & (US$/Unit)
Table 104. Global Favipiravir Price by Type (2024-2029) & (US$/Unit)
Table 105. Global Favipiravir Sales by Application (2018-2023) & (K Units)
Table 106. Global Favipiravir Sales by Application (2024-2029) & (K Units)
Table 107. Global Favipiravir Sales Market Share by Application (2018-2023)
Table 108. Global Favipiravir Sales Market Share by Application (2024-2029)
Table 109. Global Favipiravir Revenue by Application (2018-2023) & (US$ Million)
Table 110. Global Favipiravir Revenue by Application (2024-2029) & (US$ Million)
Table 111. Global Favipiravir Revenue Market Share by Application (2018-2023)
Table 112. Global Favipiravir Revenue Market Share by Application (2024-2029)
Table 113. Global Favipiravir Price by Application (2018-2023) & (US$/Unit)
Table 114. Global Favipiravir Price by Application (2024-2029) & (US$/Unit)
Table 115. Key Raw Materials
Table 116. Raw Materials Key Suppliers
Table 117. Favipiravir Distributors List
Table 118. Favipiravir Customers List
Table 119. Favipiravir Industry Trends
Table 120. Favipiravir Industry Drivers
Table 121. Favipiravir Industry Restraints
Table 122. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. FavipiravirProduct Picture
Figure 5. Global Favipiravir Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Favipiravir Market Size (2018-2029) & (US$ Million)
Figure 7. Global Favipiravir Sales (2018-2029) & (K Units)
Figure 8. Global Favipiravir Average Price (US$/Unit) & (2018-2029)
Figure 9. Brand Drug Product Picture
Figure 10. Generic Drug Product Picture
Figure 11. Influenza Viruses Product Picture
Figure 12. COVID-19 Product Picture
Figure 13. Others Product Picture
Figure 14. Global Favipiravir Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Favipiravir, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Favipiravir, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Favipiravir Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Favipiravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Favipiravir Sales by Region in 2022
Figure 21. Global Favipiravir Revenue by Region in 2022
Figure 22. North America Favipiravir Market Size by Country in 2022
Figure 23. North America Favipiravir Sales Market Share by Country (2018-2029)
Figure 24. North America Favipiravir Revenue Market Share by Country (2018-2029)
Figure 25. United States Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Favipiravir Market Size by Country in 2022
Figure 28. Europe Favipiravir Sales Market Share by Country (2018-2029)
Figure 29. Europe Favipiravir Revenue Market Share by Country (2018-2029)
Figure 30. Germany Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Favipiravir Market Size by Country in 2022
Figure 36. Asia Pacific Favipiravir Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Favipiravir Revenue Market Share by Country (2018-2029)
Figure 38. China Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Favipiravir Market Size by Country in 2022
Figure 48. Latin America Favipiravir Sales Market Share by Country (2018-2029)
Figure 49. Latin America Favipiravir Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Favipiravir Market Size by Country in 2022
Figure 54. Middle East and Africa Favipiravir Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Favipiravir Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Favipiravir Sales Market Share by Type (2018-2029)
Figure 60. Global Favipiravir Revenue Market Share by Type (2018-2029)
Figure 61. Global Favipiravir Price (US$/Unit) by Type (2018-2029)
Figure 62. Global Favipiravir Sales Market Share by Application (2018-2029)
Figure 63. Global Favipiravir Revenue Market Share by Application (2018-2029)
Figure 64. Global Favipiravir Price (US$/Unit) by Application (2018-2029)
Figure 65. Favipiravir Value Chain
Figure 66. Favipiravir Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Favipiravir Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. FavipiravirProduct Picture
Figure 5. Global Favipiravir Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Favipiravir Market Size (2018-2029) & (US$ Million)
Figure 7. Global Favipiravir Sales (2018-2029) & (K Units)
Figure 8. Global Favipiravir Average Price (US$/Unit) & (2018-2029)
Figure 9. Brand Drug Product Picture
Figure 10. Generic Drug Product Picture
Figure 11. Influenza Viruses Product Picture
Figure 12. COVID-19 Product Picture
Figure 13. Others Product Picture
Figure 14. Global Favipiravir Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Favipiravir, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Favipiravir, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Favipiravir Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Favipiravir Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Favipiravir Sales by Region in 2022
Figure 21. Global Favipiravir Revenue by Region in 2022
Figure 22. North America Favipiravir Market Size by Country in 2022
Figure 23. North America Favipiravir Sales Market Share by Country (2018-2029)
Figure 24. North America Favipiravir Revenue Market Share by Country (2018-2029)
Figure 25. United States Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Favipiravir Market Size by Country in 2022
Figure 28. Europe Favipiravir Sales Market Share by Country (2018-2029)
Figure 29. Europe Favipiravir Revenue Market Share by Country (2018-2029)
Figure 30. Germany Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Favipiravir Market Size by Country in 2022
Figure 36. Asia Pacific Favipiravir Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Favipiravir Revenue Market Share by Country (2018-2029)
Figure 38. China Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Favipiravir Market Size by Country in 2022
Figure 48. Latin America Favipiravir Sales Market Share by Country (2018-2029)
Figure 49. Latin America Favipiravir Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Favipiravir Market Size by Country in 2022
Figure 54. Middle East and Africa Favipiravir Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Favipiravir Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Favipiravir Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Favipiravir Sales Market Share by Type (2018-2029)
Figure 60. Global Favipiravir Revenue Market Share by Type (2018-2029)
Figure 61. Global Favipiravir Price (US$/Unit) by Type (2018-2029)
Figure 62. Global Favipiravir Sales Market Share by Application (2018-2029)
Figure 63. Global Favipiravir Revenue Market Share by Application (2018-2029)
Figure 64. Global Favipiravir Price (US$/Unit) by Application (2018-2029)
Figure 65. Favipiravir Value Chain
Figure 66. Favipiravir Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Favipiravir Industry Opportunities and Challenges
